SCHEMBL10742547

SCHEMBL10742547

C[S+]([O-])c1cccc(-c2nc3nccnc3[nH]2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ METAP2 P50579 1/20 0.44
▸ METAP1 P53582 1/20 0.44
▸ AURKA O14965 4/20 0.41
▸ KDM4E B2RXH2 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ THRB P10828 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ PKM P14618 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ STAT6 P42226 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ HIF1A Q16665 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10739956 0.86 METAP2 (0.42) METAP2METAP1AURKAKDM4EMEN1
SCHEMBL10740001 0.84 METAP2 (0.40) METAP2METAP1AURKAKDM4EMEN1
SCHEMBL10737696 0.83 METAP2 (0.45) METAP2METAP1AURKAMGAMGAA
SCHEMBL10741398 0.81 METAP2 (0.40) METAP2METAP1AURKAKDM4EMEN1
SCHEMBL10736658 0.80 METAP2 (0.39) METAP2METAP1AURKAKDM4EMEN1
SCHEMBL10742732 0.80 METAP2 (0.39) METAP2METAP1AURKAKDM4EMEN1
SCHEMBL10740844 0.77 METAP2 (0.40) METAP2METAP1AURKAKDM4EMEN1
SCHEMBL10734514 0.77 METAP2 (0.40) METAP2METAP1KDM4EHPGDHSD17B10
SCHEMBL10753612 0.76 CCNB2 (0.54) METAP2METAP1AURKAMGAMGAA
SCHEMBL10742079 0.76 METAP2 (0.50) METAP2METAP1AURKAKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4654344-A ALSO AFFECT BLOOD PRESSURE AND MYOCARDIAL CONTRACTIONS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1987-03-31 — — US disclosed
EP-0093951-B1 2-ARYL-TETRAAZAINDENES MERCK PATENT GmbH (DE) 1986-10-29 — — EP disclosed
US-4575505-A Pharmaceutical compositions containing 2-aryltetraazaindenes for treating ulcers or cardiac insufficiency or blood pressure abnormalities MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1986-03-11 — — US disclosed
US-4477454-A INDOTROPIC AGENTS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1984-10-16 — — US disclosed
EP-0093951-A2 2-Aryl-tetraazaindenes MERCK PATENT GmbH (DE) 1983-11-16 — — EP disclosed
Send feedback